Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Amphetamine is a central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy; it is also used to treat binge eating disorder in the form of lisdexamfetamine. Historically, it has been used to treat nasal congestion and depression.
History, Community, Culture & Applications
Explore the main themes, entities and connections around Amphetamine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
effects dextroamphetamine dopamine also use doses drug therapeutic lisdexamfetamine may monoamine used adhd treatment addiction taar1 brain norepinephrine symptoms high
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Amphetamine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Amphetamine | Addiction liability | Moderate | 1.00 | infobox |
| Amphetamine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Amphetamine | ATC code | N06BA01 (WHO) N06BA02 (WHO) N06BA12 (WHO) | 1.00 | infobox |
| Amphetamine | Bioavailability | Oral: ~90% | 1.00 | infobox |
| Amphetamine | Boiling point | 203 °C (397 °F) at 760 mmHg | 1.00 | infobox |
| Amphetamine | CAS Number | 300-62-9 Y | 1.00 | infobox |
| Amphetamine | ChEBI | CHEBI:2679 Y | 1.00 | infobox |
| Amphetamine | ChEMBL | ChEMBL405 Y | 1.00 | infobox |
| Amphetamine | ChemSpider | 13852819 Y | 1.00 | infobox |
| Amphetamine | Chirality | Racemic mixture | 1.00 | infobox |
| Amphetamine | CompTox Dashboard (EPA) | DTXSID4022600 | 1.00 | infobox |
| Amphetamine | Density | .936 g/cm3 at 25 °C | 1.00 | infobox |
| Amphetamine | Dependence liability | Physical: None Psychological: Moderate | 1.00 | infobox |
| Amphetamine | Drug class | Stimulant; anorectic; norepinephrine-dopamine releasing agent | 1.00 | infobox |
| Amphetamine | DrugBank | DB00182 Y | 1.00 | infobox |
| Amphetamine | Duration of action | IR dosing: 3–6 hours XR dosing: 8–12 hours | 1.00 | infobox |
| Amphetamine | ECHA InfoCard | 100.005.543 | 1.00 | infobox |
| Amphetamine | Elimination half-life | D-amph: 9–11 hours L-amph: 11–14 hours pH-dependent: 7–34 hours | 1.00 | infobox |
| Amphetamine | Excretion | Primarily renal; pH-dependent range: 1–75% | 1.00 | infobox |
| Amphetamine | Formula | C9H13N | 1.00 | infobox |
| Amphetamine | IUPHAR/BPS | 4804 | 1.00 | infobox |
| Amphetamine | KEGG | D07445 Y | 1.00 | infobox |
| Amphetamine | Legal status | AU: S8 (Controlled drug) | 1.00 | infobox |
| Amphetamine | Legal status | BR: Class A3 (Psychoactive drugs) | 1.00 | infobox |
| Amphetamine | Legal status | CA: Schedule I | 1.00 | infobox |
| Amphetamine | Legal status | DE: Anlage III (Special prescription form required) | 1.00 | infobox |
| Amphetamine | Legal status | NZ: Class B | 1.00 | infobox |
| Amphetamine | Legal status | UK: Class B | 1.00 | infobox |
| Amphetamine | Legal status | US: Schedule II | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.